SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-23-007158
Filing Date
2023-09-28
Accepted
2023-09-28 09:00:08
Documents
84
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ipix_10k.htm   iXBRL 10-K 1650557
2 CONSENT ipix_ex231.htm EX-23.1 2775
3 CERTIFICATION ipix_ex311.htm EX-31.1 8225
4 CERTIFICATION ipix_ex321.htm EX-32.1 3529
  Complete submission text file 0001477932-23-007158.txt   6739545

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ipix-20230630.xsd EX-101.SCH 83772
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20230630_lab.xml EX-101.LAB 393019
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20230630_cal.xml EX-101.CAL 56592
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20230630_pre.xml EX-101.PRE 346363
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20230630_def.xml EX-101.DEF 233536
78 EXTRACTED XBRL INSTANCE DOCUMENT ipix_10k_htm.xml XML 919604
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-37357 | Film No.: 231286386
SIC: 2834 Pharmaceutical Preparations